close icon

Bristol-Myers: Elliott Wave Setup can Double the Price

Bristol-Myers Squibb is in the process of acquiring Celgene in a $74 billion dollar cash-and-stock deal including debt. The deal faced opposition from hedge funds Wellington Management and Starboard Value, but ultimately gained shareholder approval on April 12th.

Arbitrageurs, who aim to profit from the discrepancy between the market price and the deal closing price, seem to have shorted BMY stock as a hedge, in order to protect their returns. The stock is set to open at $45.64 today, down from $54.38 in early March. In reality, BMY stock has been under pressure since July 2016, when it reached an all-time high of $77.12 a share.

The acquisition is expected to close in Q3 2019. From then on, management will have to deal with shareholder dilution, debt reduction and the integration of Celgene into Bristol-Myers. Despite the high quality of Celgene’s business, risks for long-term BMY investors have increased significantly. A lot can go wrong, but the actual outcome – positive or negative – will remain unknown for some time.

Bristol-Myers, A Pattern Has Emerged

Fortunately, we can look at the situation from another angle. It looks like all the news around BMY stock in the last three years, all the earnings reports, drug successes and failures, analysts’ upgrades and downgrades led to the formation of a recognizable Elliott Wave pattern. Take a look at it on the daily price chart of Bristol-Myers Squibb below.

Bristol-Myers setting the stage for a 100% rally

The daily chart reveals that the entire decline from $77.12 can be seen as an A-B-C flat correction. Waves A and B are simple a-b-c zigzags, while wave C appears to be an ending diagonal.

Prior to this retracement, BMY stock was in an uptrend. According to the Wave theory, once a correction is over the larger trend resumes. If we apply this here, it makes sense to expect a bullish reversal as wave 5 of C is poised to complete the entire pattern soon.

Despite all the risks, the market seems ready to give the BMY-Celgene deal its vote of confidence. The anticipated rally is supposed to regain all the value lost since July 2016. If this count is correct, a revisit of $77 a share is quite possible. Once there, $90 will not be too far away.

Did you like this analysis? Similar Elliott Wave setups occur in the Forex, crypto and commodity markets, as well. Our Elliott Wave Video Course can teach you how to uncover them yourself!

Stay informed with our newsletter

Latest Elliott Wave analysis on different topics delivered to you weekly.

Privacy policy
You may also like:

Rapid7 Doubles As Elliott Wave Setup Bears Fruit

We first wrote about Rapid7 in late-August 2019. The stock was hovering above $55.50, but the structure of the post-2016 uptrend suggested a notable decline was in progress. In March 2020, it fell to $31.34, down 52.5% from its all-time high. A month later, with RPD still below $47, we shared our bullish stance on…

Read More »

PNC Financial – Elliott Wave Analysis Works Yet Again

Earnings at PNC Financial suffered last year along with the entire financial sector. Net income before extraordinary items came in at $2.95B in 2020, down from $5.35 in 2019 for a 45% reduction. In our opinion, amid the biggest crisis since the Great Depression, the fact that PNC and its peers even managed to stay…

Read More »

Betting on 3i Stock a Year Ago Pays Off in Spades

The first time we wrote about 3i Group was in late-October 2019. The stock was hovering around 1100 pence a share following a 1000% gain in the past ten years. Needless to say, few thought a major decline was even possible. Fortunately, Elliott Wave analysis helped us see the bulls cannot be trusted. Five months…

Read More »

Ahead of Hibbett ‘s Unlikely Surge to New Records

Hibbett Sports Inc. is an American sporting goods retailer with more than 1000 stores in over 30 states. We first wrote about the company in the summer of 2017. The stock was trading below $16 a share back then, following a decline from as high as $68.31 in late-2013. At first glance Hibbett looked like…

Read More »

Walgreens Stock Confirms Downtrend is Over

Walgreens stock had been declining for over five years between 2015 and 2020. One of the largest pharmaceutical retailers in the world reached an all-time high of $97.30 in August 2015. In late-October 2020, it fell to $33.36, losing almost 66% from the record. It must have been difficult for Walgreens investors to keep a…

Read More »

Interpublic on the Verge of Doubling Amid Pandemic

We first wrote about Interpublic in March 2018. The stock had just reached $26 a share, but we thought an Elliott Wave correction can “easily erase about 50% of Interpublic ’s market capitalization.” Two years later, during the coronavirus panic in March 2020, IPG fell to $11.63, down 55% from the 2018 high. Fortunately, the…

Read More »

Expedia Acts As If Travel Restrictions Do Not Exist

We last wrote about Expedia in mid-2020. Countries around the globe had mostly closed their borders, the COVID-19 vaccine was still just a hopeful prospect and the summer travel season was practically ruined. No wonder the stock of Expedia, one of the largest travel booking companies, was down 46% from its 2017 high. Yet, during…

Read More »

More analyses